Current Opionion ED-BOARD.indd

First Page		Document Content
Date: 2014-01-22 14:10:38 Gastrointestinal cancer Lung cancer Multiple endocrine neoplasia Insulinoma MEN1 Carcinoid Sunitinib Neuroendocrine cell Chromogranin A Medicine Oncology Neuroendocrine tumor		Current Opionion ED-BOARD.indd Add to Reading List Source URL: www.carcinoid.org Download Document from Source Website File Size: 132,12 KB Share Document on Facebook

	EDITORIAL Serum Pancreastatin The Long Sought Universal, Sensitive, Specific Tumor Marker for Neuroendocrine Tumors? Tetsuhide Ito, MD, PhD,* Hisato Igarashi, MD, PhD,* and Robert T. Jensen, MDÞ DocID: 1pbVK - View Document
	ORIGINAL ARTICLE Validation of Serum Versus Plasma Measurements of Chromogranin A Levels in Patients With Carcinoid Tumors Lack of Correlation Between Absolute Chromogranin A Levels and Symptom Frequency DocID: 1p1DF - View Document
	ORIGINAL ARTICLE A Prospective Evaluation of the Effect of Chronic Proton Pump Inhibitor Use on Plasma Biomarker Levels in Humans Daniel Raines, MD,* Maria Chester, RN, BSN,Þ Anne E. Diebold, BS,þ DocID: 1oRMp - View Document
	ORIGINAL ARTICLE Development of a Highly Sensitive and Specific Carboxy-Terminal Human Pancreastatin Assay to Monitor Neuroendocrine Tumor Behavior Thomas M. O’Dorisio, MD,* Siegfried R. Krutzik, PhD,Þ Eugene A. Wolt DocID: 1oIE2 - View Document
	NEUROENDOCRINE TUMOURS Endocrine-Related Cancer[removed]–462 The importance of the measurement of circulating markers in patients with DocID: EDVh - View Document